PHILADELPHIA, Pa. , Feb. 8, 2024 /PRNewswire/ — A securities fraud lawsuit has been filed against BioVie Inc. (“BioVie” or the “Company”) (NASDAQ: BIVI). The lawsuit is captioned Olmstead v. BioVie Inc. et al., No. 3:24-cv-00035 (D. Nev.), and is filed on behalf of purchasers of BioVie’s…